Intrapartum prophylaxis of group B streptococcal disease in Israel: Guidelines and practice

Israel Medical Association Journal

Volumn 7, Issue 3, 2005, Pages 156-159

  Goldstick, Orly ^a,c   Jakobi, Peter ^b,c  

^a CLALIT HEALTH SERVICES   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antibiotic prophylaxis; Delivery; Epidemiology; Group B streptococcus; Guidelines

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CLINICAL PRACTICE; DELIVERY ROOM; FEMALE; HEALTH CARE FACILITY; HUMAN; INCIDENCE; INTERVIEW; ISRAEL; MEDICAL SPECIALIST; MEDICOLEGAL ASPECT; PERINATAL INFECTION; PRACTICE GUIDELINE; PROPHYLAXIS; QUESTIONNAIRE; STREPTOCOCCUS AGALACTIAE; TELEPHONE;

DELIVERY, OBSTETRIC; FEMALE; HUMANS; ISRAEL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PREGNANCY; QUESTIONNAIRES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 15844386362     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease: Revised guidelines from CDC. MMWR 2002;51(RR-11):1-21.
2. Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease: A public health perspective. MMWR 1996;45:1-24.
3. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
4. Jakobi P, Goldstick O, Sujov P, Itskovitz-Eldor J. Intrapartum prophylaxis for perinatal group B streptococcal disease: Do the CDC guidelines apply in Israel? Experience of Rambam Medical Center. Isr J Obstet Gynecol 2000;11:47-50.
5. Schimmel MS, Eidelman AI, Rudensky B, et al. Epidemiology of group B streptococcal colonization and infection in Jerusalem, 1989-1991. Isr J Med Sci 1994;30:349-51.
6. Weintraub Z, Regev R, Iancu TC, et al. Perinatal group B infections in Israel. Isr J Med Sci 1983;19:900-2.
7. Eidelman AI, Rudensky B, Ferne M, Weintraub O, Isacshon M. Epidemiology of group B streptococci in an Israeli hospital. Isr J Med Sci 1983;19:903-5.
8. Eidelman AI, Rudensky B, Turgeman D, et al. Epidemiology of group B streptococcal colonization and disease in mothers and infants: Update of ongoing 10-year Jerusalem study. Isr J Med Sci 1990;26:71-3.
9. Greenberg D, Shinwell ES, Yagupsky P, et al. A prospective study of neonatal sepsis and meningitis in southern Israel. Pediatr infect Dis J 1997;8:768-73.
10. Marchaim D, Hallak M, Gortzak-Uzan L, Peled N, Riesenberg K, Schlaeffer F. Risk factors for carriage of Group B Streptococcus in southern Israel. IMAJ 2003;5:646-8.
11. Jakobi P, Goldstick O, Sujov P, Itskovitz-Eldor J. New CDC guidelines for prevention of perinatal group B streptococcal disease [Letterl. Lancet 1996;348:969.
12. Jakobi P, Goldstick O, Sujov P, Itskovitz-Eldor J. New CDC guidelines for prevention of perinatal group B streptococcal disease [Letter]. Lancet 2003;361:351.
13. Jakobi P, Itskovitz-Eldor J. Prevention of perinatal group B streptococcal disease in light of an unknown maternal carriage rate in Israel [Letter]. Harefuah 2000;139:242 (Hebrew).
14. Jakobi P. Antibiotic prophylaxis in the delivery room - a slippery slope [Editorial]. IMAJ 2002;4:323-5.
15. Eisenberg VH, Schimmel MS, Samueloff A. Prevention of group B streptococcal infection in Israel: To screen or not to screen? Bull Isr Soc Obstet Gynecol 2003;1:27-37.
16. Schrag SJ, Zywicki S, Farley MM, et al. Group B Streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
17. Spaetgens R, DeBella K, Ma D, Robertson S, Mucenski M, Davies HD. Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens. Obstet Gynecol 2002;100:525-33.
18. Edwards RK, Clark P, Sistrom CL, Duff P. Intrapartum antibiotic prophylaxis. 1: Relative effects of recommended antibiotics on Gram-negative pathogens. Obstet Gynecol 2002;100:534-9.
19. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birthweight infants. N Engl J Med 2002;347:240-7.
20. Trijbels-Smeulders MA, Kollee LA, Adriaanse AH, Kimpen JL, Gerards LJ. Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe. Pediatr Infect Dis J 2004;23:172-3.
21. Kenyon S, Brocklehourst P, Blackburn A, Taylor DJ. Antenatal screening and intrapartum management of Group B Streptococcus in the UK. Br J Obstet Gynaecol 2004;111:226-30.
22. Stan CM, Boulvain M, Bovier PA, Auckenthaler R, Berner M, Irion O. Choosing a strategy to prevent neonatal early-onset group B streptococcal sepsis: economic evaluation. Br J Obstet Gynaecol 2001;108:840-7.
23. Lockwood CJ. I'll admit it, I was wrong about GBS screening [Editorial]. Contemp Ob Gyn 2002;47:8-11.
24. Gibbs RS, Hall RT, Yow MD, McCracken GH, Nelson JD. Consensus: Perinatal prophylaxis for group B streptococcal infection. Pediatr Infect Dis J 1992;11:179-83.
25. Queenan JT. GBS prevention: National guidelines at last. Contemp Ob Gyn 1996;41:8-11.